Co‐immunization with L‐Myc enhances CD8 + or CD103 + DCs mediated tumor‐specific multi‐functional CD8 + T cell responses-Reference-Cited by-同舟云学术

Co‐immunization with L‐Myc enhances CD8 + or CD103 + DCs mediated tumor‐specific multi‐functional CD8 + T cell responses

Published:2021-07-10 Issue:9 Volume:112 Page:3469-3483
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Chai Dafei¹²³,Zhang Zichun¹⁴,Jiang Nan¹⁴,Ding Jiage¹³,Qiu Dong⁴,Shi Shang Yuchen⁵,Wang Gang¹²³^ORCID,Fang Lin¹²³,Li Huizhong¹²³,Tian Hui¹²³,Yang Jie¹²³,Zhang Qing¹²³,Zheng Junnian²³^ORCID

Affiliation:

1. Cancer Institute, Xuzhou Medical University Xuzhou China

2. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy Cancer Institute, Xuzhou Medical University Xuzhou China

3. Center of Clinical Oncology Affiliated Hospital of Xuzhou Medical University Xuzhou China

4. Department of Urology Affiliated Hospital of Xuzhou Medical University Xuzhou China

5. Department of Radiation Oncology Affiliated Hospital of Xuzhou Medical University Xuzhou China

Funder

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Natural Science Research of Jiangsu Higher Education Institutions of China

Qinglan Project of Jiangsu Province of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15044

Reference41 articles.

1. Cancer statistics, 2020

2. Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy

3. The immunology of renal cell carcinoma;Diaz‐Montero CM;Nat Rev,2020

4. Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma

5. Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy;Expert Opinion on Drug Delivery;2024-09-08

2. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09

3. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials;Materials Today Bio;2024-08

4. The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma;npj Vaccines;2023-08-04

5. DEC-205 receptor targeted poly(lactic-co-glycolic acid) nanoparticles containing Eucommia ulmoides polysaccharide enhances the immune response of foot-and-mouth disease vaccine in mice;International Journal of Biological Macromolecules;2023-02